ESC Premium Access

Aspirin at 120: cardioprotection and beyond

Event: ESC CONGRESS 2017
Topic: Drug therapy
Session type: Satellite Symposium
Sponsored by Bayer AG
Date: 27 August 2017
Time: 12:45 - 13:45

Session

4 presentations in this session

Introduction and welcome - Aspirin at 120: cardioprotection and beyond.

Speaker: Professor C. Patrono (Rome, IT)
Thumbnail

Aspirin progress report: 120 years and the research continues.

Speaker: Professor H. Bueno (Madrid, ES)
Thumbnail

Non-vascular outcomes: re-evaluating the benefit-risk profile of low-dose aspirin.

Speaker: Professor C. Patrono (Rome, IT)
Thumbnail

Identifying the aspirin patient: interactive case presentations.

Speaker: Associate Professor G. Biondi-Zoccai (Latina, IT)
Thumbnail

4 speakers from this session

Professor Carlo Patrono

Catholic University of the Sacred Heart, Rome (Italy)
4 presentations
0 follower

Professor Hector Bueno

National Centre for Cardiovascular Research (CNIC), Madrid (Spain)
25 presentations
1 follower

Professor Carlo Patrono

Catholic University of the Sacred Heart, Rome (Italy)
4 presentations
0 follower

Associate Professor Giuseppe Biondi-Zoccai

Sapienza University of Rome, Latina (Italy)
5 presentations
0 follower

This platform is supported by

logo Novo Nordisk